Consistency in maintaining contact with HIV-related service providers: An analysis of the AIDS Cost and Services Utilization Study (ACSUS)

Journal of Community Health

Volumn 23, Issue 2, 1998, Pages 137-152

  Niemcryk, Steve J ^a,c   Bedros, Ani ^a   Marconi, Katherine M ^a   O'Neill, Joseph F ^b  

^a Office of Science and Epidemiology

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c HIV/AIDS Bureau   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SERVICE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AMBULATORY CARE; COMMUNITY-INSTITUTIONAL RELATIONS; CONTINUITY OF PATIENT CARE; FEMALE; HEALTH CARE SURVEYS; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUESTIONNAIRES; SAMPLING STUDIES; TIME FACTORS; UNITED STATES; URBAN HEALTH SERVICES;

EID: 0031978666     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018713524788     Document Type: Article

References (16)

1. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995; 333:1534-1539.
2. Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with sasquinavir, zidovudine, and zalcitavine. AIDS Clinical Trials Group. N Engl J Med 1996; 334:1011-1017.
3. Phillips AN, Eron J, Bartlett J, et al. Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. AIDS 1997; 11:169-175.
4. Centers for Disease Control and Prevention. First 500,000 AIDS cases-United States, 1995. MMWR 1995; 44:849-853.
5. MacGowan RJ, Brackbill RM, Rugg DL, et al. Sex, drugs and HIV counseling and testing: A prospective study of behavior-change among methadone-maintenance clients in New England. AIDS 1997; 11:229-235.
6. Marx R, Katz MH, Park M, Gurley RJ. Meeting the service needs of HIV-infected persons: Is the Ryan White CARE Act succeeding? J Acquir Immune Defic Syndr Hum Retroviral 1997; 14:44-55.
7. Stein MD, Piette J, Mor V, et al. Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med 1991; 6:35-40.
8. Mor V, Fleishman JA, Dresser M, Piette J. Variation in health service use among HIV-infected patients. Med Care 1992; 30:17-29.
9. Turner BJ, Markson LE, McKee JJ, Houchens R, Fanning T. Health care delivery, Zidovudine use, and survival of women and men with AIDS. J Acquir Immune Defic Syndr 1994; 8:120-162.
10. Schur CL, Berk M. Health insurance coverage of persons with HIV-related illness: data from the ACSUS Screener. AIDS Cost and Services Utilization Survey (ACSUS) Report No. 2. AHCPR Pub. No. 94-0009 Rockville, MD: Agency for Health Care Policy and Research, 1994.
11. Fleishman JA, Hsia DC, Hellinger FJ. Correlates of medical service utilization among people with HIV infection. Health Serv Res 1994; 29:527-548.
12. Bastani R, Kaplan CP, Maxwell AE, et al. Initial and repeat mammography screening in a low income multi-ethnic population in Los Angeles. Cancer Epidemiol Biomarkers Prev 1995; 4:161-167.
13. Lambrew JM, DeFriese GH, Carey TS, et al. The effects of having a regular doctor on access to primary care. Med Care 1996; 34:138-151.
14. Decks SG, Smith M, Holodniy M, Kahn JO. HIV-1 Protease Inhibitors: A review for clinicians. JAMA 1997; 277:145-153.
15. Grumbach K, Keane D, Bindman A. Primary care and public emergency department overcrowding. Am J Public Health 1993; 83:372-378.
16. Moore RD, Chaisson RE. Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland. J Acquir Immune Defic Syndr Hum Retroviral 1997; 14:223-231.